Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel 2-substituted-quinoxaline analogs with potential antiproliferative activity against breast cancer: insights into cell cycle arrest, topoisomerase II, and EGFR activity.
Salem MG, Abu El-Ata SA, Elsayed EH, Mali SN, Alshwyeh HA, Almaimani G, Almaimani RA, Almasmoum HA, Altwaijry N, Al-Olayan E, Saied EM, Youssef MF. Salem MG, et al. Among authors: mali sn. RSC Adv. 2023 Nov 9;13(47):33080-33095. doi: 10.1039/d3ra06189b. eCollection 2023 Nov 7. RSC Adv. 2023. PMID: 37954422 Free PMC article.
Molecular docking, QSAR, pharmacophore modeling, and dynamics studies of some chromone derivatives for the discovery of anti-breast cancer agents against hormone-dependent breast cancer.
Arvindekar SA, Mohole S, Patil A, Mane P, Arvindekar A, Mali SN, Thorat B, Rawat R, Sharma S. Arvindekar SA, et al. Among authors: mali sn. J Biomol Struct Dyn. 2023;41(24):14757-14770. doi: 10.1080/07391102.2023.2190803. Epub 2023 Mar 30. J Biomol Struct Dyn. 2023. PMID: 36995997
Mechanistic QSAR modeling derived virtual screening, drug repurposing, ADMET and in-vitro evaluation to identify anticancer lead as lysine-specific demethylase 5a inhibitor.
Jawarkar RD, Zaki MEA, Al-Hussain SA, Al-Mutairi AA, Samad A, Masand V, Humane V, Mali S, Alzahrani AYA, Rashid S, Elossaily GM. Jawarkar RD, et al. J Biomol Struct Dyn. 2024 Feb 22:1-31. doi: 10.1080/07391102.2024.2319104. Online ahead of print. J Biomol Struct Dyn. 2024. PMID: 38385447
Carbonylbis(hydrazine-1-carbothioamide) derivatives as a new class of α-glucosidase inhibitors and their mechanistic insights via molecular docking and dynamic simulations.
Naseem S, Fatima S, Ullah S, Khan A, Mali SN, Jawarkar RD, Syed A, Elgorban AM, Al-Harrasi A, Shafiq Z. Naseem S, et al. Among authors: mali sn. Arch Pharm (Weinheim). 2024 Mar;357(3):e2300604. doi: 10.1002/ardp.202300604. Epub 2023 Dec 26. Arch Pharm (Weinheim). 2024. PMID: 38148299
56 results